Non-small Cell Lung Cancer
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Guangzhou University of Traditonal Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who are new confirmed as Non-small Cell Lung Cancer by histopathology and/or cytopathology can use chemotherapy as primary treatment. 2. Men and women range in age from 18-75 years. 3. The Eastern Cooperative Oncology Group (ECOG) performance status (PS) score is 0-2. 4. Lifetime is expected to be 3 months or more. 5. Patients at least have one measurable target lesion examined by CT or MRI according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. 6. Informed consent form is signed willingly by all study participants.
Exclusion criteria
Exclusion criteria: 1. The result of genetic testing is positive for one of the three biomarkers (Epidermal growth factor receptor [EGFR], Anaplastic lymphoma kinase [ALK] and c-ros oncogene receptor kinase [ROS]). 2. They are intended to immunotherapy. 3. They are intended to radiotherapy. 4. The status of brain metastasis (BM) is unstable. 5. Pregnant women or breast feeding women. 6. Mental illness or mental retardation. 7. Patients are intolerance or allergic to study drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival;Objective Response Rate;Disease Control Rate;The duration of drug use;One-year survival rate;Quality of Life; | — |
Countries
China
Contacts
Public ContactLizhu Lin
The First Affiliated Hospital of Guangzhou University of Traditonal Chinese Medicine
Outcome results
None listed